ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹790 Cr | ₹731 Cr | ₹711 Cr | ₹688 Cr | ₹656 Cr |
What is the latest Total Non-Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹790 Cr |
| Mar2025 | ₹731 Cr |
| Mar2024 | ₹711 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹656 Cr |
How is Total Non-Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹790 Cr | 8.07 | |
| Mar2025 | ₹731 Cr | 2.79 | |
| Mar2024 | ₹711 Cr | 3.35 | |
| Mar2023 | ₹688 Cr | 4.98 | |
| Mar2022 | ₹656 Cr | - | |
Compare Total Non-Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,595.8 Cr | -3.3% | -14.2% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -3.3% |
-14.2% |
-2.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses